{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:14:20Z","timestamp":1789978460453,"version":"4.0.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.jneuroim.2010.02.001","type":"journal-article","created":{"date-parts":[[2010,2,21]],"date-time":"2010-02-21T04:28:53Z","timestamp":1266726533000},"page":"5-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Antibodies to gangliosides and ganglioside complexes in Guillain\u2013Barr\u00e9 syndrome and Fisher syndrome: Mini-review"],"prefix":"10.1016","volume":"223","author":[{"given":"Kenichi","family":"Kaida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2010.02.001_bib1","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1212\/WNL.53.9.2122","article-title":"Rapidly progressive, predominantly motor Guillain\u2013Barr\u00e9 syndrome with anti-GalNAc-GD1a antibodies","volume":"53","author":"Ang","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/mus.880160603","article-title":"Acute conduction block in vitro following exposure to antiganglioside sera","volume":"16","author":"Arasaki","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nbd.2007.07.008","article-title":"Anti-ganglioside antibodies alter presynaptic release and calcium influx","volume":"28","author":"Buchwald","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410310619","article-title":"Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome","volume":"31","author":"Chiba","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib5","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1212\/WNL.43.10.1911","article-title":"Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain\u2013Barr\u00e9 syndrome: clinical and immunohistochemical studies","volume":"43","author":"Chiba","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0006-8993(96)01123-7","article-title":"Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome","volume":"745","author":"Chiba","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib7","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1212\/WNL.43.4.809","article-title":"Localization of GM1 and Gal(beta 1\u20133)GalNAc antigenic determinants in peripheral nerve","volume":"43","author":"Corbo","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0165-5728(03)00156-5","article-title":"Effects on axonal conduction of anti-ganglioside sera and sera from patients with Guillain\u2013Barre syndrome","volume":"139","author":"Dilley","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib10","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1093\/brain\/awf258","article-title":"Localization of major gangliosides in the PNS: implications for immune neuropathies","volume":"125","author":"Gong","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib11","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1523\/JNEUROSCI.4279-04.2005","article-title":"Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy","volume":"25","author":"Goodfellow","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1172\/JCI6837","article-title":"Monoclonal antibodies raised against Guillain\u2013Barr\u00e9 syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle\u2013nerve preparations","volume":"104","author":"Goodyear","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1172\/JCI37338","article-title":"The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice","volume":"119","author":"Greenshields","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.410390512","article-title":"Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy","volume":"39","author":"Hafer-Macko","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib15","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410400414","article-title":"Acute motor axonal neuropathy: an antibody-mediated attack on axolemma","volume":"40","author":"Hafer-Macko","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1026524820177","article-title":"Cell adhesion\/recognition and signal transduction through glycosphingolipid microdomain","volume":"17","author":"Hakomori","year":"2000","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/B:GLYC.0000044844.95878.cf","article-title":"Carbohydrate-to-carbohydrate interaction, through glycosynapse, as a basis of cell recognition and membrane organization","volume":"21","author":"Hakomori","year":"2004","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib18","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/brain\/awh231","article-title":"Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy","volume":"127","author":"Halstead","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ana.20546","article-title":"Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome","volume":"58","author":"Halstead","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib20","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/1531-8249(199906)45:6<758::AID-ANA10>3.0.CO;2-N","article-title":"Anti-GalNAc-GD1a antibody-associated Guillain\u2013Barr\u00e9 syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance","volume":"45","author":"Hao","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jneuroim.2004.09.018","article-title":"Effects of phospholipids on antiganglioside antibody reactivity in GBS","volume":"159","author":"Hirakawa","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib22","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/brain\/120.12.2159","article-title":"The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons","volume":"120","author":"Hirota","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6","article-title":"Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain\u2013Barr\u00e9 syndrome","volume":"45","author":"Ho","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib24","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1016\/S0021-9258(18)68935-5","article-title":"Gangliosides GM2, IV4GalNAcGM1b, and IV4GalNAcGC1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy","volume":"263","author":"Ilyas","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.410400209","article-title":"Campylobacter jejuni infections and anti-GM1 antibodies in Guillain\u2013Barr\u00e9 syndrome","volume":"40","author":"Jacobs","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib86","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0165-5728(00)00451-3","article-title":"Guillain-Barr\u00e9 syndrome with IgM antibody to the ganglioside GalNAc-GD1a","volume":"113","author":"Kaida","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib26","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1586\/ern.09.77","article-title":"Guillain\u2013Barr\u00e9 syndrome \u2014 update on immunobiology and treatment","volume":"9","author":"Kaida","year":"2009","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/brain\/123.1.116","article-title":"Guillain\u2013Barre syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a","volume":"123","author":"Kaida","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/01.WNL.0000081229.88862.C6","article-title":"GalNAc-GD1a in human peripheral nerve. Target sites of anti-ganglioside antibody","volume":"61","author":"Kaida","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ana.20222","article-title":"Ganglioside complexes: as new target antigens in Guillain\u2013Barr\u00e9 syndrome","volume":"56","author":"Kaida","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib30","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/jnnp.2006.087940","article-title":"Anti-ganglioside complex antibodies in Miller Fisher syndrome","volume":"77","author":"Kaida","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jneuroim.2006.09.013","article-title":"Anti-ganglioside complex antibodies associated with severe disability in GBS","volume":"182","author":"Kaida","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1212\/01.wnl.0000317093.57106.33","article-title":"GD1b-specific antibody induces ataxia in Guillain\u2013Barr\u00e9 syndrome","volume":"71","author":"Kaida","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib33","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/01.wnl.0000335160.72184.7d","article-title":"GM1\/GalNAc-GD1a complex: a target for pure motor Guillain\u2013Barr\u00e9 syndrome","volume":"71","author":"Kaida","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib34","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/glycob\/cwp027","article-title":"Antiganglioside antibodies and their pathophysiological effects on Guillain\u2013Barr\u00e9 syndrome and related disorders\u2014a review","volume":"19","author":"Kaida","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib35","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1136\/jnnp.2007.142950","article-title":"Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain\u2013Barr\u00e9 syndromes","volume":"79","author":"Kanzaki","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/jnnp.71.1.123","article-title":"Range of cross reactivity of anti-GM1 IgG antibody in Guillain\u2013Barr\u00e9 syndrome","volume":"71","author":"Koga","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib37","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.72.6.767","article-title":"Anti-GT1a IgG in Guillain\u2013Barr\u00e9 syndrome","volume":"72","author":"Koga","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jneuroim.2007.05.014","article-title":"Origin of ganglioside complex antibodies in Guillain\u2013Barr\u00e9 syndrome","volume":"188","author":"Kuijf","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib40","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/mus.880160710","article-title":"Localization of GM1 and GD1b antigens in the human peripheral nervous system","volume":"16","author":"Kusunoki","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1212\/WNL.47.1.237","article-title":"GM1b is a new member of antigen for serum antibody in Guillain\u2013Barr\u00e9 syndrome","volume":"47","author":"Kusunoki","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib42","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.410390404","article-title":"Experimental sensory neuropathy induced by sensitization with ganglioside GD1b","volume":"39","author":"Kusunoki","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib43","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/1531-8249(199903)45:3<400::AID-ANA19>3.0.CO;2-Y","article-title":"Monospecific anti-GD1b IgG is required to induce rabbit ataxic neuropathy","volume":"45","author":"Kusunoki","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib44","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/(SICI)1097-4598(199908)22:8<1071::AID-MUS10>3.0.CO;2-0","article-title":"Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia","volume":"22","author":"Kusunoki","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib45","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410440210","article-title":"IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain\u2013Barr\u00e9 syndrome","volume":"44","author":"Kuwabara","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib46","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/ana.10275","article-title":"Differences in membrane properties of axonal and demyelinating Guillain\u2013Barre syndromes","volume":"52","author":"Kuwabara","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1523\/JNEUROSCI.4017-06.2007","article-title":"Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model","volume":"27","author":"Lehmann","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib48","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1167\/iovs.08-3333","article-title":"Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles","volume":"50","author":"Liu","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sbi.2009.06.001","article-title":"Gangliosides in cell recognition and membrane protein regulation","volume":"19","author":"Lopez","year":"2009","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib50","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1093\/brain\/awn074","article-title":"Structural requirements of anti-GD1a antibodies determine their target specificity","volume":"131","author":"Lopez","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1212\/WNL.54.1.33","article-title":"Physiologic\u2013pathologic correlation in Guillain\u2013Barr\u00e9 syndrome in children","volume":"54","author":"Lu","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib52","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1023\/B:NEUR.0000020632.41508.83","article-title":"Glycobiology of the neuromuscular junction","volume":"32","author":"Martin","year":"2003","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib53","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1212\/WNL.56.9.1227","article-title":"Guillain\u2013Barr\u00e9 syndrome associated with IgG monospecific to ganglioside GD1b","volume":"56","author":"Miyazaki","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib54","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jns.2004.01.005","article-title":"Clinical correlates of serum anti-GT1a IgG antibodies","volume":"219","author":"Nagashima","year":"2004","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib55","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/archneur.64.10.1519","article-title":"Continuous spectrum of pharyngeal\u2013cervical\u2013brachial variant of Guillain\u2013Barr\u00e9 syndrome","volume":"64","author":"Nagashima","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib56","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.expneurol.2006.11.015","article-title":"IgG anti-GalNAc-GD1a antibody inhibits the voltage-dependent calcium channel currents in PC12 pheochromocytoma cells","volume":"204","author":"Nakatani","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11064-008-9735-4","article-title":"Cav2.1 voltage-dependent Ca2+ channel current is inhibited by serum from select patients with Guillain\u2013Barr\u00e9 syndrome","volume":"34","author":"Nakatani","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib58","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/jnnp.70.1.50","article-title":"Anti-GQ1b IgG antibody syndrome: clinical and immunological range","volume":"70","author":"Odaka","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib59","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jneuroim.2009.06.017","article-title":"Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain\u2013Barr\u00e9 syndromes","volume":"214","author":"Ogawa","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib60","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/j.1471-4159.1990.tb04930.x","article-title":"Different ceramide compositions of gangliosides between human motor and sensory nerves","volume":"55","author":"Ogawa-Goto","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/1531-8249(199902)45:2<189::AID-ANA9>3.0.CO;2-T","article-title":"Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates","volume":"45","author":"Plomp","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib62","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-510X(99)00328-7","article-title":"Immunohistochemical localization of cytokines, C5b-9 and ICAM-1 in peripheral nerve of Guillain\u2013Barr\u00e9 syndrome","volume":"174","author":"Putzu","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib63","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ana.410380516","article-title":"Anti-ganglioside GM1 antibodies in Guillain\u2013Barr\u00e9 syndrome and their relationship to Campylobacter jejuni infection","volume":"38","author":"Rees","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib64","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/glycob\/cwp049","article-title":"Analysis of lectin binding to glycolipid complexes using combinatorial glycoarrays","volume":"19","author":"Rinaldi","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib65","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410310407","article-title":"Experimental conduction block induced by serum from a patient with anti-GM1 antibodies","volume":"31","author":"Santoro","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib66","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/brain\/122.3.449","article-title":"The distribution of ganglioside-like moieties in peripheral nerves","volume":"122","author":"Sheikh","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib67","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/35036052","article-title":"Lipid rafts and signal transduction","volume":"1","author":"Simons","year":"2000","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib68","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ana.33333","article-title":"Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons","volume":"54","author":"Susuki","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib69","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/glia.20503","article-title":"Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers","volume":"55","author":"Susuki","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib70","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1523\/JNEUROSCI.4401-06.2007","article-title":"Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers","volume":"27","author":"Susuki","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib71","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0021-9258(19)44435-9","article-title":"Isolation and structural determination of a novel ganglioside, a disialosylpentahexosylceramide from human brain","volume":"248","author":"Svennerholm","year":"1973","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib72","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1023\/A:1020221410895","article-title":"Anti-ganglioside antibodies bind with enhanced affinity to gangliosides containing very long chain fatty acids","volume":"27","author":"Tagawa","year":"2002","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib73","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jns.2004.07.011","article-title":"Neurophysiological and immunohistochemical studies on Guillain\u2013Barr\u00e9 syndrome with IgG anti-GalNAc-GD1a antibodies\u2014effects on neuromuscular transmission","volume":"225","author":"Taguchi","year":"2004","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib74","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2007.09.010","article-title":"Apoptosis of primary sensory neurons in GD1b-induced sensory ataxic neuropathy","volume":"209","author":"Takada","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib75","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ana.410370405","article-title":"Antibodies against GM1 ganglioside affect K+and Na+currents in isolated rat myelinated nerve fibers","volume":"37","author":"Takigawa","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib76","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1073\/pnas.0709619104","article-title":"Ganglioside GM2\/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82\/cMet-mediated pathway","volume":"105","author":"Todeschini","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib77","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nature05816","article-title":"Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins","volume":"446","author":"Varki","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib78","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/brain\/118.4.841","article-title":"Guillain\u2013Barr\u00e9 syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain\u2013Barr\u00e9 Study Group","volume":"118","author":"Visser","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib79","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/brain\/awg207","article-title":"Distinct time pattern of complement activation and cytotoxic T cell response in Guillain\u2013Barr\u00e9 syndrome","volume":"126","author":"Wanschitz","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib80","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/1097-4598(200009)23:9<1414::AID-MUS13>3.0.CO;2-0","article-title":"Anti-GM1 antibodies can block neuronal voltage-gated sodium channels","volume":"23","author":"Weber","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib81","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.02.001_bib82","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jneuroim.2008.05.028","article-title":"The role of complement and complement regulators in mediating motor nerve terminal injury in murine models of Guillain\u2013Barre syndrome","volume":"201\u2013202","author":"Willison","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib83","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/1531-8249(200003)47:3<314::AID-ANA6>3.0.CO;2-C","article-title":"Clinical features and response to treatment in Guillain\u2013Barr\u00e9 syndrome associated with antibodies to GM1b ganglioside","volume":"47","author":"Yuki","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib84","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ana.1012","article-title":"Animal model of axonal Guillain\u2013Barr\u00e9 syndrome induced by sensitization with GM1 ganglioside","volume":"49","author":"Yuki","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.02.001_bib85","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.0402391101","article-title":"Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain\u2013Barr\u00e9 syndrome","volume":"101","author":"Yuki","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281000041X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281000041X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:14:53Z","timestamp":1759047293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557281000041X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":84,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S016557281000041X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.02.001","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibodies to gangliosides and ganglioside complexes in Guillain\u2013Barr\u00e9 syndrome and Fisher syndrome: Mini-review","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}